Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries
- E. Vigliar
- , R. Cepurnaite
- , E. Alcaraz-Mateos
- , S. Z. Ali
- , Z. W. Baloch
- , C. Bellevicine
- , M. Bongiovanni
- , P. Botsun
- , D. Bruzzese
- , L. Bubendorf
- , R. Buttner
- , S. Canberk
- , A. Capitanio
- , C. Casadio
- , E. Cazacu
- , B. Cochand-Priollet
- , A. D'Amuri
- , C. Eloy
- , M. Engels
- , G. Fadda
*Autore corrispondente per questo lavoro
- University of Naples Federico II
- Hospital General Universitario Reina Sofia
- SYNLAB International GmbH
- Laboratory of Pathology CSD
- University of Basel
- Universidade Do Porto
- Linköping University
- IRCCS Istituto Europeo di Oncologia - Milano
- State University of Medicine and Pharmacy "Nicolae Testemiţanu"
- Assistance publique – Hôpitaux de Paris
- University of Cologne
- A.O.U. Polyclinic G. Martino
- University of Pisa
- Cantonal Institute of Pathology
- CHU de Nice
- Izumi City General Hospital
- Tampere University
- University of Texas MD Anderson Cancer Center
- Kapoor Path Laboratories
- Johns Hopkins University
- University of the Witwatersrand
- Baku Pathology Center
- Namik Kemal University
- Portsmouth Hospitals University NHS Trust
- Center for Diagnostic Pathology
- Duke University
- A.C.Camargo Cancer Center
- Hôpital Americain
- Charing Cross Hospital
- PALGA Foundation
- KU Leuven
- University of Salerno
Risultato della ricerca: Contributo in rivista › Articolo